1. Home
  2. CHCT vs OCGN Comparison

CHCT vs OCGN Comparison

Compare CHCT & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community Healthcare Trust Incorporated

CHCT

Community Healthcare Trust Incorporated

N/A

Current Price

$18.05

Market Cap

410.6M

Sector

Real Estate

ML Signal

N/A

Logo Ocugen Inc.

OCGN

Ocugen Inc.

N/A

Current Price

$1.34

Market Cap

387.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHCT
OCGN
Founded
2014
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
410.6M
387.3M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
CHCT
OCGN
Price
$18.05
$1.34
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$18.50
$7.00
AVG Volume (30 Days)
169.3K
6.2M
Earning Date
02-17-2026
03-04-2026
Dividend Yield
10.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$119,547,000.00
$5,370,000.00
Revenue This Year
$7.32
$35.88
Revenue Next Year
$6.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.40
14.26
52 Week Low
$13.23
$0.52
52 Week High
$20.28
$1.96

Technical Indicators

Market Signals
Indicator
CHCT
OCGN
Relative Strength Index (RSI) 77.17 41.83
Support Level $16.62 $1.31
Resistance Level $18.19 $1.70
Average True Range (ATR) 0.35 0.09
MACD 0.07 -0.04
Stochastic Oscillator 96.83 10.98

Price Performance

Historical Comparison
CHCT
OCGN

About CHCT Community Healthcare Trust Incorporated

Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: